Good Distribution Practices for Pharmaceutical Products

The term "good distribution practice" refers to the minimum standards that a wholesale distributor must adhere to in order to ensure the continued quality and integrity of medicines throughout the supply chain. GDP also applies to the sourcing, storage, and transportation of active pharmaceutical ingredients and other ingredients used in the pharmaceutical manufacturing process.

GDP compliance enables businesses to ensure that:

• medicines distributed throughout the supply chain are authorised in accordance with European Union (EU) legislation.
• medications are always stored properly, including during transportation.
• contamination by other products or by other substances is avoided.

CyCert conducts audits of companies that manufacture, distribute, and transport medicinal products and ingredients used in the manufacture of the medicines in accordance with the Guidelines of 5 November 2013 on Good Distribution Practices for Medicinal Products for Human Use (2013/C 343/01).

Any Organisation interested to be audited according to the above scheme should contact Cyprus Certification Company via e-mail (info@CyCert.org.cy) or telephone (+ 357 22 411435) for additional information.

To obtain a quotation, click on GET A QUOTE and complete the online application. Alternatively, you may complete and send the certification application to info@CyCert.org.cy or by fax to +357 22 519115.

To learn more about the certification process, please click here.